Life Sciences

Ethical Dilemmas and Potential of Gene Editing for Designer Babies
Technology Ethical Dilemmas and Potential of Gene Editing for Designer Babies

Gene editing has opened up remarkable possibilities in the field of medicine and genetics, but it also presents profound ethical and societal dilemmas. With the potential to eradicate hereditary diseases and enhance specific traits, the concept of "designer babies" has transitioned from

How is Innovation Reshaping Healthcare Investments?
Process How is Innovation Reshaping Healthcare Investments?

The healthcare investment landscape has experienced significant shifts and surged with remarkable resilience and growth since the onset of the COVID-19 pandemic. In 2025, the sector continues to evolve, marking substantial transformations in global healthcare private equity, mergers and

Advancements in Bioengineered Teeth Promise Revolution in Dental Implants
Care Advancements in Bioengineered Teeth Promise Revolution in Dental Implants

Imagine going to the dentist in the future and, instead of having metal screws implanted into your jaw, getting new teeth grown specifically for you from your own cells. Traditional dental implants, while functional and visually acceptable, often come with various complications such as

Decoding Wellness Trends: Separating Science from Social Media Hype
Care Decoding Wellness Trends: Separating Science from Social Media Hype

In an age where social media influencers have become the new health gurus, the line between genuine wellness practices and fleeting fads has never been more blurred. One day there's a buzz about the miraculous benefits of celery juice, and the next, everyone is raving about intermittent

Can AI-Derived REC-994 Be a Breakthrough for Cerebral Cavernous Malformation?
Data and Information Can AI-Derived REC-994 Be a Breakthrough for Cerebral Cavernous Malformation?

Recursion Pharmaceuticals has announced promising clinical data for its lead AI-derived drug candidate, REC-994, aimed at treating cerebral cavernous malformation (CCM). The findings were presented at the International Stroke Conference (ISC) in Los Angeles, marking a significant milestone in

GE Healthcare Invests $138M to Boost Contrast Media Production in Ireland
Business GE Healthcare Invests $138M to Boost Contrast Media Production in Ireland

In a strategic move to meet the rising global demand for contrast media agents, GE Healthcare is channeling a substantial investment of $138 million into expanding its production capabilities at an existing facility in Cork, Ireland. This initiative is designed to address the crucial need for

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later